The U.S. Food and Drug Administration on Wednesday said it has approved Bayer's drug for patients with a type of lung cancer ...

Targeted therapies, guided by molecular testing, offer significant benefits, including fewer side effects and personalization ...

Just a few months after Boehringer Ingelheim broke into the oncology space with the first drug that can target a rare tumor ...

The FDA announced accelerated approval of sevabertinib (Hyrnuo) for HER2-positive non-small cell lung cancer (NSCLC).

Joanne Cure, 78, survived stage 4 lung cancer after being given two years to live, crediting her faith, determination, and ...

Living with lung cancer often means spending more time in waiting rooms than in the moments that matter. But that could ...

The Food and Drug Administration (FDA) granted traditional approval to Imdelltra (tarlatamab-dlle) for adult patients with ...

Nuvalent filed a new drug application for an experimental non-small cell lung cancer treatment with the Food and Drug Administration.

Dr. Timothy Leclair is an Intermountain Health interventional pulmonary specialist who specialize in lung cancer treatment at Intermountain Medical ...

MONTGOMERY, Ala. ( WSFA) - November is Lung Cancer Awareness Month putting a national spotlight on early detection and better ...

The U.S. Food and Drug Administration said on Wednesday that it has approved Bayer's drug for patients with a form of lung ...